EPO


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

EPO

(Exclusive Provider Organization) See healthcare IT.
Copyright © 1981-2019 by The Computer Language Company Inc. All Rights reserved. THIS DEFINITION IS FOR PERSONAL USE ONLY. All other reproduction is strictly prohibited without permission from the publisher.
References in periodicals archive ?
The intervention will end with the EPO elections on Aug.
On the other hand, there is an increased mortality rate with recombinant human EPO treatment in stroke patients due to the toxicity of the high dose of EPO, this toxicity may partially result from increased hematocrit (Hct)-associated side effects, such as hypertension and thromboembolism.
A joint operation was initiated by EPA and District Administration of Peshawar against the violators of EPO and sealed different entities including marble units, printing presses, coal crushing units etc over creating air, noise pollution besides discharging untreated waste.
DG EPA had issued Environmental Protection Orders (EPOs) last month to 60 marble units and seven printing presses over noise pollution.
In an interview, she emphasized that the mechanism of benefit doesn't appear to be related to EPO's signature ability to boost red blood cell production and raise hemoglobin levels.
- Europe led the global EPO drug market in 2013 closely followed by North America
By drawing on this, an attempt is made in the present work to prepare hybrid plasticizer from low molecular weight poly(ethylene glycol) (PEG) and epoxidized palm oils (EPO) to improve brittleness of PLA.
EPO is a glycoprotein hormone that can increase the proliferation and differentiation of BFU/CFU-E and maturation of red blood cells.
Hematocrit (HCT) percent and iron profile were estimated in moderate altitude patients receiving or not receiving Epo therapy, and compared to the corresponding patients living at low altitude.
In addition to the protective effect of EPO on myocardial ischemia, studies on animal models have shown that EPO can also reduce reperfusion tissue injuries.
The key tendencies of recent years in terms of the geographical origin of patent filings are confirmed: 93,600 filings (35.3% of the total; growth of +/-0% compared with 2012) at the EPO originated from its 38 member countries, followed by the United States (24.5% of the total; +2%), Japan (19.7%; +1.2%), China (8.4%; +18%) and South Korea (6.4%; +16.6%).